Related Experiment Video
Updated: Sep 15, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Ehlers-Danlos syndrome type IV. Clinical and molecular aspects and guidelines for diagnosis and management
1Department of Medical Genetics, University Hospital, Ghent, Belgium.
Abstract:
The clinical, biochemical and molecular characteristics of Ehlers-Danlos syndrome type IV are reviewed. The numerous clinical manifestations result from the generalized and excessive tissue fragility characteristic for this disorder. The variability in cutaneous involvement may hamper recognition of the condition and requires careful clinical examination. Clinical diagnosis can be confirmed by demonstration of a collagen type III defect. The severity of the phenotype appears to be related mainly to the intrinsic stability of mutant type III collagen protein and its disturbing effect on normal collagen fibrillogenesis in the extracellular matrix.
Related Concept Videos
Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can exist in...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease IV: Nursing Management
Heart Failure IV: Classification and Diagnostic Evaluation
Peripheral Artery Disease IV: Nursing Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care

